ES2190692B1 - Formulacion farmaceutica de amoxicilina y clavulanato de potasio. - Google Patents

Formulacion farmaceutica de amoxicilina y clavulanato de potasio.

Info

Publication number: ES2190692B1
Authority: ES; Spain
Prior art keywords: potassium clavulanate; amoxicillin; pharmaceutical formulation; formulation; amoxycline
Prior art date: 1999-04-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn - After Issue

Application number

ES200000935A

Other languages

English (en)

Spanish (es)

Other versions

ES2190692A1 (es

Inventor

Kevin Storm

Creighton Conley

John Roush

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Beecham Pharmaceuticals Pte Ltd

Original Assignee

Beecham Pharmaceuticals Pte Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-13

Filing date

2000-04-11

Publication date

2004-11-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2190692(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-11 Application filed by Beecham Pharmaceuticals Pte Ltd filed Critical Beecham Pharmaceuticals Pte Ltd

2003-08-01 Publication of ES2190692A1 publication Critical patent/ES2190692A1/es

2004-11-16 Application granted granted Critical

2004-11-16 Publication of ES2190692B1 publication Critical patent/ES2190692B1/es

2020-04-11 Anticipated expiration legal-status Critical

Status Withdrawn - After Issue legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Peptides Or Proteins (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

ES200000935A 1999-04-13 2000-04-11 Formulacion farmaceutica de amoxicilina y clavulanato de potasio. Withdrawn - After Issue ES2190692B1 (es)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date
US12907499P	1999-04-13	1999-04-13
US60/129074		1999-04-13
US15072799P	1999-08-25	1999-08-25
US60/150727		1999-08-25
US15981399P	1999-10-15	1999-10-15
US60/159813		1999-10-15

Publications (2)

Publication Number	Publication Date
ES2190692A1 ES2190692A1 (es)	2003-08-01
ES2190692B1 true ES2190692B1 (es)	2004-11-16

Family

ID=27383840

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES00303033T Expired - Lifetime ES2202004T3 (es)	1999-04-13	2000-04-11	Novedoso procedimiento de tratamiento usando un fuerte regimen de dosificacion de amoxicilina y clavulanato potasico.
ES200000935A Withdrawn - After Issue ES2190692B1 (es)	1999-04-13	2000-04-11	Formulacion farmaceutica de amoxicilina y clavulanato de potasio.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
ES00303033T Expired - Lifetime ES2202004T3 (es)	1999-04-13	2000-04-11	Novedoso procedimiento de tratamiento usando un fuerte regimen de dosificacion de amoxicilina y clavulanato potasico.

Country Status (44)

Country	Link
EP (4)	EP1044680B1 (fi)
JP (2)	JP4880125B2 (fi)
KR (1)	KR100634937B1 (fi)
CN (1)	CN100382782C (fi)
AP (1)	AP1806A (fi)
AR (1)	AR031068A1 (fi)
AT (2)	AT4327U1 (fi)
AU (1)	AU767177B2 (fi)
BE (2)	BE1013309A5 (fi)
BG (1)	BG65006B1 (fi)
BR (1)	BRPI0009719B8 (fi)
CA (1)	CA2366304C (fi)
CO (1)	CO5170471A1 (fi)
CZ (1)	CZ298801B6 (fi)
DE (3)	DE20006626U1 (fi)
DK (3)	DK1044680T3 (fi)
DZ (1)	DZ3150A1 (fi)
EA (1)	EA004310B1 (fi)
ES (2)	ES2202004T3 (fi)
FI (2)	FI20000863L (fi)
FR (1)	FR2792198A1 (fi)
GB (1)	GB2351661B (fi)
GR (1)	GR1003560B (fi)
HU (1)	HU229097B1 (fi)
IE (1)	IE20000271A1 (fi)
IL (2)	IL145580A0 (fi)
IT (1)	ITMI20000788A1 (fi)
MA (1)	MA25352A1 (fi)
MX (1)	MXPA01010377A (fi)
MY (1)	MY119953A (fi)
NL (2)	NL1014915C2 (fi)
NO (1)	NO329694B1 (fi)
NZ (1)	NZ514575A (fi)
OA (1)	OA11926A (fi)
PE (1)	PE20010053A1 (fi)
PL (1)	PL197448B1 (fi)
PT (2)	PT102450B (fi)
RO (1)	RO120817B1 (fi)
SE (1)	SE0001330L (fi)
SI (2)	SI20304A (fi)
SK (1)	SK285140B6 (fi)
TR (1)	TR200102963T2 (fi)
TW (1)	TWI235067B (fi)
WO (1)	WO2000061116A2 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9407386D0 (en)	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
NZ337247A (en) *	1995-09-07	2001-05-25	Smithkline Beecham Corp	Pharmaceutical tablet formulation comprising 875mg amoxycillin
SE9802973D0 (sv)	1998-09-03	1998-09-03	Astra Ab	Immediate release tablet
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
AU2001292185A1 (en)	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20030035839A1 (en) *	2001-05-15	2003-02-20	Peirce Management, Llc	Pharmaceutical composition for both intraoral and oral administration
WO2003004030A1 (en)	2001-07-06	2003-01-16	Endo Pharmaceuticals, Inc.	Oxymorphone controlled release formulations
GB0117618D0 (en) *	2001-07-19	2001-09-12	Phoqus Ltd	Pharmaceutical dosage form
US6863901B2 (en)	2001-11-30	2005-03-08	Collegium Pharmaceutical, Inc.	Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en)	2001-12-05	2004-12-07	Collegium Pharmaceutical, Inc.	Compositions containing both sedative and non-sedative antihistamines
WO2003084518A2 (fr)	2002-04-09	2003-10-16	Flamel Technologies	Suspension orale de microcapsules de principes actifs
EP1499303A4 (en) *	2002-04-10	2007-07-25	Fred H Miller	MULTIPHASE MULTI-COMPONENT CAPSULE SYSTEM
US20050042289A1 (en) *	2003-04-29	2005-02-24	Yamanouchi Pharma Technologies, Inc.	Tablets and methods for modified release of hydrophylic and other active agents
CA2535398C (en)	2003-08-12	2013-11-12	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
EP1541129A1 (en) *	2003-12-12	2005-06-15	Cimex AG	Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid
EP1750717B1 (en) *	2004-02-11	2017-07-19	Rubicon Research Private Limited	Controlled release pharmaceutical compositions with improved bioavailability
WO2005099672A1 (en) *	2004-04-13	2005-10-27	Ranbaxy Laboratories Limited	A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
EP1880716A1 (en) *	2006-07-19	2008-01-23	Sandoz AG	Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
EP2079453A1 (en) *	2006-10-10	2009-07-22	Penwest Pharmaceuticals Co.	Robust sustained release formulations
TR200909787A2 (tr)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000687A1 (tr)	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
CA2981752C (en)	2015-04-07	2020-08-25	Church & Dwight Co., Inc.	Multicomponent gummy compositions with hard core
CN109394718B (zh) *	2018-11-15	2021-04-27	石药集团中诺药业（石家庄）有限公司	一种阿莫西林分散片及其制备方法
CN110051637A (zh) *	2019-05-21	2019-07-26	葵花药业集团北京药物研究院有限公司	阿莫西林克拉维酸钾制剂及其制备方法
WO2023208241A1 (zh) *	2022-04-29	2023-11-02	越洋医药开发(广州)有限公司	一种吡非尼酮持续性释放口服固体制剂

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0008905B1 (en) *	1978-09-06	1983-02-16	Beecham Group Plc	Pharmaceutical compositions containing two beta-lactam derivatives
IL58461A0 (en) *	1978-10-27	1980-01-31	Beecham Group Ltd	Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) *	1979-12-07	1981-06-12	Panoz Donald	Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) *	1990-04-07	1990-06-06	Beecham Group Plc	Pharmaceutical formulation
GB9109862D0 (en) *	1991-05-08	1991-07-03	Beecham Lab Sa	Pharmaceutical formulations
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
AU5863894A (en) *	1993-01-22	1994-08-15	Smithkline Beecham Plc	Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
GB9311030D0 (en) *	1993-05-28	1993-07-14	Smithkline Beecham Corp	Pharmaceutical formulations
IL109770A0 (en) *	1993-05-29	1994-11-28	Smithkline Beecham Corp	Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
GB9407386D0 (en) *	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
ITMI941169A1 (it) *	1994-06-06	1995-12-06	Smithkline Beecham Farma	Formulazioni farmaceutiche
GB9416600D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
GB9416599D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
NZ337247A (en) *	1995-09-07	2001-05-25	Smithkline Beecham Corp	Pharmaceutical tablet formulation comprising 875mg amoxycillin
GB9616536D0 (en) *	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
CA2280857A1 (en) *	1997-02-14	1998-08-20	Smithkline Beecham Laboratoires Pharmaceutiques	Pharmaceutical formulations comprising amoxocyllin and clavulanate
JP2000510530A (ja) *	1997-03-11	2000-08-15	アルマッグアル	金属被覆方法、および金属被覆装置
SE9700885D0 (sv) *	1997-03-12	1997-03-12	Astra Ab	New pharmaceutical formulation
US6428813B1 (en) *	1997-03-25	2002-08-06	Takeda Chemical Industries, Ltd.	Gastrointestinal mucosa-adherent pharmaceutical composition
JP3746901B2 (ja) *	1997-10-15	2006-02-22	ユニ・チャーム株式会社	開閉自在容器
GB9815532D0 (en) *	1998-07-17	1998-09-16	Lek Pharmaceutical & Cvhemical	Pharmaceutical suspension formulation
GB9818927D0 (en) *	1998-08-28	1998-10-21	Smithkline Beecham Plc	Pharmaceutical formulation
US6225304B1 (en) *	1999-02-17	2001-05-01	Pharmaceutical Solutions, Inc.	Soluble forms of amoxicillin and treatment of animals

2000
- 2000-04-11 EP EP00303033A patent/EP1044680B1/en not_active Expired - Lifetime
- 2000-04-11 DK DK00303033T patent/DK1044680T3/da active
- 2000-04-11 TW TW089106937A patent/TWI235067B/zh not_active IP Right Cessation
- 2000-04-11 NL NL1014915A patent/NL1014915C2/nl not_active IP Right Cessation
- 2000-04-11 FR FR0004631A patent/FR2792198A1/fr active Pending
- 2000-04-11 IE IE20000271A patent/IE20000271A1/en not_active IP Right Cessation
- 2000-04-11 DE DE20006626U patent/DE20006626U1/de not_active Expired - Lifetime
- 2000-04-11 OA OA1200100257A patent/OA11926A/en unknown
- 2000-04-11 JP JP2000610449A patent/JP4880125B2/ja not_active Expired - Lifetime
- 2000-04-11 CN CNB008086737A patent/CN100382782C/zh not_active Expired - Lifetime
- 2000-04-11 SE SE0001330A patent/SE0001330L/xx not_active Application Discontinuation
- 2000-04-11 ES ES00303033T patent/ES2202004T3/es not_active Expired - Lifetime
- 2000-04-11 MX MXPA01010377A patent/MXPA01010377A/es active IP Right Grant
- 2000-04-11 RO ROA200000399A patent/RO120817B1/ro unknown
- 2000-04-11 AT AT0027900U patent/AT4327U1/de not_active IP Right Cessation
- 2000-04-11 EP EP02078928A patent/EP1269997A1/en not_active Withdrawn
- 2000-04-11 IT IT2000MI000788A patent/ITMI20000788A1/it unknown
- 2000-04-11 TR TR2001/02963T patent/TR200102963T2/xx unknown
- 2000-04-11 MY MYPI20001509A patent/MY119953A/en unknown
- 2000-04-11 EP EP02078926A patent/EP1269996A1/en not_active Withdrawn
- 2000-04-11 GB GB0008923A patent/GB2351661B/en not_active Revoked
- 2000-04-11 DK DK200000602A patent/DK200000602A/da not_active Application Discontinuation
- 2000-04-11 NZ NZ514575A patent/NZ514575A/en not_active IP Right Cessation
- 2000-04-11 CO CO00026419A patent/CO5170471A1/es not_active Application Discontinuation
- 2000-04-11 KR KR1020017012988A patent/KR100634937B1/ko not_active Expired - Fee Related
- 2000-04-11 PT PT102450A patent/PT102450B/pt active IP Right Grant
- 2000-04-11 AP APAP/P/2001/002284A patent/AP1806A/en active
- 2000-04-11 EA EA200101075A patent/EA004310B1/ru not_active IP Right Cessation
- 2000-04-11 HU HU0001471A patent/HU229097B1/hu unknown
- 2000-04-11 AU AU57020/00A patent/AU767177B2/en not_active Expired
- 2000-04-11 EP EP02078927A patent/EP1270005A3/en not_active Withdrawn
- 2000-04-11 WO PCT/IB2000/000992 patent/WO2000061116A2/en not_active Ceased
- 2000-04-11 PL PL339591A patent/PL197448B1/pl unknown
- 2000-04-11 CA CA002366304A patent/CA2366304C/en not_active Expired - Lifetime
- 2000-04-11 IL IL14558000A patent/IL145580A0/xx active IP Right Grant
- 2000-04-11 BE BE2000/0255A patent/BE1013309A5/fr not_active IP Right Cessation
- 2000-04-11 AT AT00303033T patent/ATE242629T1/de active
- 2000-04-11 PE PE2000000332A patent/PE20010053A1/es not_active Application Discontinuation
- 2000-04-11 NL NL1014914A patent/NL1014914C1/nl not_active IP Right Cessation
- 2000-04-11 SI SI200000097A patent/SI20304A/sl not_active IP Right Cessation
- 2000-04-11 FI FI20000863A patent/FI20000863L/fi unknown
- 2000-04-11 SK SK534-2000A patent/SK285140B6/sk not_active IP Right Cessation
- 2000-04-11 DK DK200000133U patent/DK200000133U3/da not_active IP Right Cessation
- 2000-04-11 FI FI20000164U patent/FI4823U1/fi active
- 2000-04-11 DZ DZ003150A patent/DZ3150A1/xx active
- 2000-04-11 NO NO20001870A patent/NO329694B1/no not_active IP Right Cessation
- 2000-04-11 BR BRPI0009719A patent/BRPI0009719B8/pt not_active IP Right Cessation
- 2000-04-11 GR GR20000100122A patent/GR1003560B/el unknown
- 2000-04-11 PT PT00303033T patent/PT1044680E/pt unknown
- 2000-04-11 BE BE00/0256A patent/BE1012733A6/fr not_active IP Right Cessation
- 2000-04-11 CZ CZ20001311A patent/CZ298801B6/cs not_active IP Right Cessation
- 2000-04-11 ES ES200000935A patent/ES2190692B1/es not_active Withdrawn - After Issue
- 2000-04-11 AR ARP000101657A patent/AR031068A1/es not_active Application Discontinuation
- 2000-04-11 DE DE10017883A patent/DE10017883A1/de not_active Withdrawn
- 2000-04-11 DE DE60003255T patent/DE60003255T2/de not_active Expired - Lifetime
- 2000-04-11 BG BG104329A patent/BG65006B1/bg unknown
- 2000-04-11 SI SI200030183T patent/SI1044680T1/xx unknown
2001
- 2001-09-24 IL IL145580A patent/IL145580A/en not_active IP Right Cessation
- 2001-10-12 MA MA26356A patent/MA25352A1/fr unknown
2011
- 2011-07-22 JP JP2011161132A patent/JP2011256180A/ja active Pending

Also Published As

Publication number	Publication date
BE1013309A5 (fr)	2001-11-06
JP2002541187A (ja)	2002-12-03
CZ298801B6 (cs)	2008-02-06
BG104329A (en)	2001-11-30
CN1382040A (zh)	2002-11-27
PL197448B1 (pl)	2008-03-31
DE20006626U1 (de)	2000-10-19
NL1014915C2 (nl)	2001-02-12
FI20000863A0 (fi)	2000-04-11
ITMI20000788A1 (it)	2001-10-11
HU0001471D0 (en)	2000-06-28
SI1044680T1 (en)	2003-12-31
CZ20001311A3 (cs)	2000-11-15
IL145580A0 (en)	2002-11-10
EP1269996A1 (en)	2003-01-02
FIU20000164U0 (fi)	2000-04-11
AU5702000A (en)	2000-11-14
ATE242629T1 (de)	2003-06-15
CO5170471A1 (es)	2002-06-27
NL1014915A1 (nl)	2000-10-16
DK1044680T3 (da)	2003-09-29
DZ3150A1 (fr)	2000-10-19
CN100382782C (zh)	2008-04-23
OA11926A (en)	2006-04-12
GB2351661B (en)	2001-10-10
CA2366304A1 (en)	2000-10-19
AR031068A1 (es)	2003-09-10
BE1012733A6 (fr)	2001-02-06
TWI235067B (en)	2005-07-01
SE0001330D0 (sv)	2000-04-11
FI20000863A7 (fi)	2000-10-13
EP1270005A2 (en)	2003-01-02
EA004310B1 (ru)	2004-02-26
PT1044680E (pt)	2003-10-31
CA2366304C (en)	2004-06-29
JP4880125B2 (ja)	2012-02-22
BR0009719A (pt)	2002-01-08
NL1014914C1 (nl)	2000-10-16
SK285140B6 (sk)	2006-07-07
GB0008923D0 (en)	2000-05-31
IL145580A (en)	2007-05-15
DE10017883A1 (de)	2000-10-26
IE20000271A1 (en)	2001-04-04
BRPI0009719B8 (pt)	2021-05-25
DK200000133U3 (da)	2000-07-28
ES2202004T3 (es)	2004-04-01
NO329694B1 (no)	2010-12-06
ITMI20000788A0 (it)	2000-04-11
SE0001330L (sv)	2000-10-14
EP1044680A1 (en)	2000-10-18
BG65006B1 (bg)	2006-12-29
TR200102963T2 (tr)	2002-02-21
DE60003255D1 (de)	2003-07-17
NZ514575A (en)	2004-05-28
HU229097B1 (en)	2013-07-29
MXPA01010377A (es)	2002-10-23
AU767177B2 (en)	2003-11-06
JP2011256180A (ja)	2011-12-22
AP2001002284A0 (en)	2001-12-31
GR1003560B (el)	2001-03-16
EP1269997A1 (en)	2003-01-02
HUP0001471A2 (en)	2001-03-28
NO20001870L (no)	2000-10-16
WO2000061116A2 (en)	2000-10-19
SK5342000A3 (en)	2000-11-07
DK200000602A (da)	2000-10-14
FI20000863L (fi)	2000-10-13
HK1032741A1 (en)	2001-08-03
GB2351661A (en)	2001-01-10
AP1806A (en)	2007-12-14
AT4327U1 (de)	2001-06-25
DE60003255T2 (de)	2004-05-06
FI4823U1 (fi)	2001-02-16
FR2792198A1 (fr)	2000-10-20
KR100634937B1 (ko)	2006-10-17
SI20304A (sl)	2001-02-28
NO20001870D0 (no)	2000-04-11
PT102450B (pt)	2003-09-30
PL339591A1 (en)	2000-10-23
RO120817B1 (ro)	2006-08-30
EA200101075A1 (ru)	2002-04-25
EP1044680B1 (en)	2003-06-11
ES2190692A1 (es)	2003-08-01
HUP0001471A3 (en)	2001-10-29
EP1270005A3 (en)	2006-05-17
MA25352A1 (fr)	2001-12-31
PT102450A (pt)	2001-02-01
KR20020015312A (ko)	2002-02-27
WO2000061116A3 (en)	2001-02-01
PE20010053A1 (es)	2001-03-10
MY119953A (en)	2005-08-30
BR0009719B1 (pt)	2014-09-30

Publication	Publication Date	Title
ES2190692B1 (es)	2004-11-16	Formulacion farmaceutica de amoxicilina y clavulanato de potasio.
ES2602450T3 (es)	2017-02-21	Composición farmacéutica para uso dérmico para el tratamiento de la psoriasis que comprende calcipotril y betametasona
WO2000061115A3 (en)	2001-03-01	Pharmaceutical formulation comprising amoxycillin
ES2180251T3 (es)	2003-02-01	Comprimido revestido con polimero, que contiene amoxicilina y clavulanato.
ATE514424T1 (de)	2011-07-15	Pharmazeutische zubereitungen von taxanen
AR004510A1 (es)	1998-12-16	Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
EP2322146A3 (en)	2011-06-15	Microcapsule formulations comprising two pharmaceutically active ingredients
AR013506A1 (es)	2000-12-27	Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
AR023972A1 (es)	2002-09-04	Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
UY26372A1 (es)	2000-12-29	"imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
MX9307555A (es)	1995-01-31	Derivados de paclitaxel y formulaciones farmaceuticas que los contienen.
AR020001A1 (es)	2002-03-27	COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
AR016798A1 (es)	2001-08-01	Uso de una cepa de lactobacillus para la elaboracion de un medicamento
ES2167061T3 (es)	2002-05-01	Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
DE60312523D1 (de)	2007-04-26	Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
UY27532A1 (es)	2003-05-30	Forma de dosificación de liberación controlada dual.
AR008306A1 (es)	1999-12-29	Uso de amoxicilina y clavulanato en la fabricacion de un medicamento
AR034517A1 (es)	2004-02-25	Formulacion farmaceutica
JP2002526407A5 (fi)	2006-11-30
MX354985B (es)	2018-03-28	Conjunto de juguete de construcción.
ITMI20022292A1 (it)	2004-04-30	9a-azalidi ad attivita' antiinfiammatoria.
AR045783A1 (es)	2005-11-16	Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
IT1263840B (it)	1996-09-04	Formulazioni orali di ubidecarenone in forma di capsule
AR008886A1 (es)	2000-02-23	Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
BR0112847A (pt)	2003-06-24	Uso de uma forma de dosagem sólida

Legal Events

Date	Code	Title	Description
2003-08-01	EC2A	Search report published	Date of ref document: 20030801 Kind code of ref document: A1
2004-11-16	FG2A	Definitive protection	Ref document number: 2190692B1 Country of ref document: ES
2005-05-01	FA2A	Application withdrawn	Effective date: 20050401

Date

Code

Title

Description

2003-08-01

EC2A

Search report published

Date of ref document: 20030801

Kind code of ref document: A1

2004-11-16

FG2A

Definitive protection

Ref document number: 2190692B1

Country of ref document: ES

2005-05-01

FA2A

Application withdrawn

Effective date: 20050401